Last updated: June 5, 2026

Back to directory

Diagnocat medical AI product profile

Dental CBCT AI and viewer platform for radiological reports, 3D visualization, and FDA-cleared second-read support for periapical radiolucency detection.

Screenshot of the official Diagnocat product page
Medical imaging and radiology

Best fit

Dental and oral-radiology teams that need CBCT-focused second-reader support and structured reports while keeping licensed clinicians accountable.

Primary use case
AI-assisted CBCT review, radiological reports, 3D visualization, tooth charts, segmentation, and second-read support for dental professionals
Audience
Dental practices, oral radiologists, implant and endodontic practices, dental specialists, and DSOs using CBCT imaging
Risk level
High
Pricing signal
Practice and specialty pricing; verify Viewer, Radiological Report, CBCT, support, and country-specific availability.
Official sources
6 official sources

Compare within workflow: Medical imaging and radiology · comparison shortlist · source index

Regulatory, privacy, evidence, and workflow lens

Product-specific review. These product-specific signals summarize what the cited sources imply before treating Diagnocat as safe for a local clinical, operational, or research workflow.

Regulatory / FDAUse the FDA-cleared CBCT indication narrowly: second-read support for periapical radiolucency in permanent teeth for trained dental professionals, not a replacement for complete clinical judgment.
PrivacyReview DICOM routing, cloud storage, desktop or web viewer access, report sharing, support access, HIPAA materials, SOC 2 evidence, retention, and business-associate terms.
EvidenceValidate against local CBCT cases, scanner protocols, oral-radiologist review, periapical-radiolucency prevalence, segmentation accuracy, and how often clinicians dismiss AI findings.
WorkflowBest deployed after CBCT necessity is independently determined, with clinician review of heat maps, report edits, patient-communication boundaries, and documented final interpretation.

Where Diagnocat fits

Diagnocat describes FDA-cleared dental image-processing, 3D visualization, radiological reports, and HIPAA/SOC 2-aligned product claims; FDA K252934 lists Diagnocat as a CADe second-read tool for periapical radiolucency on previously acquired maxillofacial CBCT scans of permanent teeth in adults.

Not for: Replacing a complete CBCT review, use before a clinician independently determines CBCT is clinically justified, unsupported patient ages, or broad claims beyond the cleared indication.

What to verify before using Diagnocat

Source links

Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.

Related medical AI products